Welcome to LookChem.com Sign In|Join Free
  • or
2-(4-bromo-phenylsulfanyl)benzoic acid benzyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1005513-47-2

Post Buying Request

1005513-47-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1005513-47-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1005513-47-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,5,5,1 and 3 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1005513-47:
(9*1)+(8*0)+(7*0)+(6*5)+(5*5)+(4*1)+(3*3)+(2*4)+(1*7)=92
92 % 10 = 2
So 1005513-47-2 is a valid CAS Registry Number.

1005513-47-2Relevant academic research and scientific papers

THIOARYL SUBSTITUTED INHIBITORS OF ZINC PROTEASES AND THEIR USE

-

Page/Page column 47-48, (2009/10/01)

There are described compounds having the general formula (I) below and their pharmaceutically acceptable salts thereof, wherein E, X, m, q, R1, R2, n and ZBG have the meanings reported in the description useful, in therapy, as inhibi

Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors

Nuti, Elisa,Panelli, Laura,Casalini, Francesca,Avramova, Stanislava I.,Orlandini, Elisabetta,Santamaria, Salvatore,Nencetti, Susanna,Tuccinardi, Tiziano,Martinelli, Adriano,Cercignani, Giovanni,D'Amelio, Nicola,Maiocchi, Alessandro,Uggeri, Fulvio,Rossello, Armando

experimental part, p. 6347 - 6361 (2010/03/24)

Overexpression of macrophage elastase (MMP-12), a member of the matrix metalloproteinases family, can be linked to tissue remodeling and degradation in some inflammatory processes, such as chronic obstructive pulmonary disease (COPD), emphysema, rheumatoi

INHIBITORS OF ZINC PROTEASES THIOARYL SUBSTITUTED AND THEIR USE

-

Page/Page column 74-75; 102-103, (2008/06/13)

There are described compounds having the general formula (I) below and their pharmaceutically acceptable salts thereof, wherein E, X, m, q, R1, R2, n and ZBG have the meanings reported in the description useful, in therapy, as inhibi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1005513-47-2